You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

Pulmonology

On demand events

ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation

Join experts Henrik Watz, Mona Bafadhel, and Alberto Papi for an educational symposium on the link between underlying drivers of COPD with type 2 inflammation and cumulative patient burden, exploring the role of type 2 cytokines, and current and emerging therapies.

MD, PhD

Henrik Watz +2 more

Learning objectives

Link the underlying drivers of COPD with type 2 inflammation to cumulative patient burden
Communicate the differential roles of type 2 cytokines and mediators as markers or drivers of disease in COPD with type 2 inflammation
Understand the current and emerging therapeutic options for COPD with type 2 inflammation

About these experts

Pulmonology

MD, PhD

Henrik Watz

Professor, University of Kiel, Kiel, Germany | Medical Director, Velocity Clinical Research Grosshansdorf, Grosshansdorf, Germany

Pulmonology

MD, PhD

Mona Bafadhel

Chair of Respiratory Medicine Director of the King’s Centre for Lung Health

Pulmonology

MD, PhD

Alberto Papi

Professor of Respiratory Medicine | University of Ferrara; Director of the Respiratory Unit of the Department of Emergency Medicine | Saint Anna University Hospital, Ferrara, Italy

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region